News & Opinion

» opinion and cell & molecular biology

Covering the life sciences inside and out

Most Recent

image: Opinion: The Precarious Earth

Opinion: The Precarious Earth

By | June 18, 2012

People are currently driving the planet on a crash course with global stability. Something must be done.

39 Comments

image: Opinion: What’s Wrong with COI?

Opinion: What’s Wrong with COI?

By | June 12, 2012

Financial “conflicts of interest” should not be so quickly condemned. Industry relationships are unequivocally beneficial.

0 Comments

image: Opinion: Justice Delayed, Health Denied

Opinion: Justice Delayed, Health Denied

By | June 4, 2012

African justice systems must change to help curb HIV and tuberculosis transmission in prisons.

12 Comments

image: Next Generation: The Brain Bot

Next Generation: The Brain Bot

By | May 29, 2012

A 30-year-old technique to record the electrical activity of neurons gets a robotic makeover.

0 Comments

image: Opinion: Pressured to Commercialize

Opinion: Pressured to Commercialize

By | May 28, 2012

Is the push for science to save the still flailing economy a threat to scientific research?

5 Comments

image: Could Stem Cells Cure MS?

Could Stem Cells Cure MS?

By | May 23, 2012

A growth factor isolated from human stem cells shows promising results in a mouse model of multiple sclerosis.

1 Comment

image: Opinion: Saving Species through Economics

Opinion: Saving Species through Economics

By | May 21, 2012

Successful conservation depends on an economy that doesn’t incentivize destruction of species and habitats.

4 Comments

image: Live Slow, Die Old

Live Slow, Die Old

By | May 17, 2012

Ancient bacteria living in deep-sea sediments are alive—but with metabolisms so slow that it’s hard to tell.

13 Comments

image: Synchronized Clocks

Synchronized Clocks

By | May 16, 2012

Researchers identify the first circadian clock component conserved across all three domains of life.

1 Comment

image: Opinion: Misleading Drug Trials

Opinion: Misleading Drug Trials

By | May 14, 2012

Amgen’s incomplete report on an early major trial of epoetin misled the medical community about the anemia drug’s risks and benefits—and helped make Amgen rich.

23 Comments

Popular Now

  1. Major German Universities Cancel Elsevier Contracts
  2. Running on Empty
    Features Running on Empty

    Regularly taking breaks from eating—for hours or days—can trigger changes both expected, such as in metabolic dynamics and inflammation, and surprising, as in immune system function and cancer progression.

  3. Most of Human Genome Nonfunctional: Study
  4. Identifying Predatory Publishers
AAAS